244 related articles for article (PubMed ID: 27739012)
1. Development of a Non-Aqueous Dispersion to Improve Intestinal Epithelial Flux of Poorly Permeable Macromolecules.
Maher S; Medani M; Carballeira NN; Winter DC; Baird AW; Brayden DJ
AAPS J; 2017 Jan; 19(1):244-253. PubMed ID: 27739012
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of intestinal absorption enhancement and local mucosal toxicity of two promoters. I. Studies in isolated rat and human colonic mucosae.
Maher S; Kennelly R; Bzik VA; Baird AW; Wang X; Winter D; Brayden DJ
Eur J Pharm Sci; 2009 Nov; 38(4):291-300. PubMed ID: 19737613
[TBL] [Abstract][Full Text] [Related]
3. Labrasol
Heade J; Maher S; Bleiel SB; Brayden DJ
J Pharm Sci; 2018 Jun; 107(6):1648-1655. PubMed ID: 29462634
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of alkylmaltosides as intestinal permeation enhancers: comparison between rat intestinal mucosal sheets and Caco-2 monolayers.
Petersen SB; Nolan G; Maher S; Rahbek UL; Guldbrandt M; Brayden DJ
Eur J Pharm Sci; 2012 Nov; 47(4):701-12. PubMed ID: 22952065
[TBL] [Abstract][Full Text] [Related]
5. Sodium caprate-induced increases in intestinal permeability and epithelial damage are prevented by misoprostol.
Brayden DJ; Maher S; Bahar B; Walsh E
Eur J Pharm Biopharm; 2015 Aug; 94():194-206. PubMed ID: 26026287
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the effects of the intestinal permeation enhancers, SNAC and sodium caprate (C
Twarog C; McCartney F; Harrison SM; Illel B; Fattal E; Brayden DJ
Eur J Pharm Sci; 2021 Mar; 158():105685. PubMed ID: 33359131
[TBL] [Abstract][Full Text] [Related]
7. Investigations of Piperazine Derivatives as Intestinal Permeation Enhancers in Isolated Rat Intestinal Tissue Mucosae.
Stuettgen V; Brayden DJ
AAPS J; 2020 Jan; 22(2):33. PubMed ID: 31989362
[TBL] [Abstract][Full Text] [Related]
8. Efficacious intestinal permeation enhancement induced by the sodium salt of 10-undecylenic acid, a medium chain fatty acid derivative.
Brayden DJ; Walsh E
AAPS J; 2014 Sep; 16(5):1064-76. PubMed ID: 24961919
[TBL] [Abstract][Full Text] [Related]
9. N-sulfonato-N,O-carboxymethylchitosan: a novel polymeric absorption enhancer for the oral delivery of macromolecules.
Thanou M; Henderson S; Kydonieus A; Elson C
J Control Release; 2007 Feb; 117(2):171-8. PubMed ID: 17184870
[TBL] [Abstract][Full Text] [Related]
10. An Assessment of the Permeation Enhancer, 1-phenyl-piperazine (PPZ), on Paracellular Flux Across Rat Intestinal Mucosae in Ussing Chambers.
Bzik VA; Brayden DJ
Pharm Res; 2016 Oct; 33(10):2506-16. PubMed ID: 27387171
[TBL] [Abstract][Full Text] [Related]
11. A mucoadhesive nanoparticulate system for the simultaneous delivery of macromolecules and permeation enhancers to the intestinal mucosa.
Makhlof A; Werle M; Tozuka Y; Takeuchi H
J Control Release; 2011 Jan; 149(1):81-8. PubMed ID: 20138935
[TBL] [Abstract][Full Text] [Related]
12. Salcaprozate sodium (SNAC) enhances permeability of octreotide across isolated rat and human intestinal epithelial mucosae in Ussing chambers.
Fattah S; Ismaiel M; Murphy B; Rulikowska A; Frias JM; Winter DC; Brayden DJ
Eur J Pharm Sci; 2020 Nov; 154():105509. PubMed ID: 32777258
[TBL] [Abstract][Full Text] [Related]
13. Thiolated polycarbophil/glutathione: defining its potential as a permeation enhancer for oral drug administration in comparison to sodium caprate.
Perera G; Barthelmes J; Vetter A; Krieg C; Uhlschmied C; Bonn GK; Bernkop-Schnürch A
Drug Deliv; 2011 Aug; 18(6):415-23. PubMed ID: 21554106
[TBL] [Abstract][Full Text] [Related]
14. Discovery of synergistic permeation enhancers for oral drug delivery.
Whitehead K; Karr N; Mitragotri S
J Control Release; 2008 Jun; 128(2):128-33. PubMed ID: 18433909
[TBL] [Abstract][Full Text] [Related]
15. In vitro interactions between the oral absorption promoter, sodium caprate (C(10)) and S. typhimurium in rat intestinal ileal mucosae.
Cox AB; Rawlinson LA; Baird AW; Bzik V; Brayden DJ
Pharm Res; 2008 Jan; 25(1):114-22. PubMed ID: 17546408
[TBL] [Abstract][Full Text] [Related]
16. Modulation of ganciclovir intestinal absorption in presence of absorption enhancers.
Shah P; Jogani V; Mishra P; Mishra AK; Bagchi T; Misra A
J Pharm Sci; 2007 Oct; 96(10):2710-22. PubMed ID: 17680662
[TBL] [Abstract][Full Text] [Related]
17. A head-to-head Caco-2 assay comparison of the mechanisms of action of the intestinal permeation enhancers: SNAC and sodium caprate (C
Twarog C; Liu K; O'Brien PJ; Dawson KA; Fattal E; Illel B; Brayden DJ
Eur J Pharm Biopharm; 2020 Jul; 152():95-107. PubMed ID: 32387703
[TBL] [Abstract][Full Text] [Related]
18. Sodium caprate enables the blood pressure-lowering effect of Ile-Pro-Pro and Leu-Lys-Pro in spontaneously hypertensive rats by indirectly overcoming PepT1 inhibition.
Gleeson JP; Frías JM; Ryan SM; Brayden DJ
Eur J Pharm Biopharm; 2018 Jul; 128():179-187. PubMed ID: 29684535
[TBL] [Abstract][Full Text] [Related]
19. Sodium glycodeoxycholate and sodium deoxycholate as epithelial permeation enhancers: in vitro and ex vivo intestinal and buccal bioassays.
Brayden DJ; Stuettgen V
Eur J Pharm Sci; 2021 Apr; 159():105737. PubMed ID: 33524502
[TBL] [Abstract][Full Text] [Related]
20. Intestinal permeation enhancers enable oral delivery of macromolecules up to 70 kDa in size.
Fein KC; Gleeson JP; Newby AN; Whitehead KA
Eur J Pharm Biopharm; 2022 Jan; 170():70-76. PubMed ID: 34879228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]